Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.

@article{Lamb2000InhaledFP,
  title={Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.},
  author={Harriet M. Lamb and Christine R. Culy and Diana Faulds},
  journal={PharmacoEconomics},
  year={2000},
  volume={18 5},
  pages={487-510}
}
UNLABELLED Contemporary asthma management guidelines list inhaled corticosteroids as the preferred controller medication for patients with persistent asthma. Despite the availability of explicit guidelines, there is evidence that these agents are underused and that guidelines are not always adhered to. Fluticasone propionate is one of several inhaled corticosteroids used for the treatment of asthma. Like other agents of its class, its efficacy is backed by extensive clinical data. More recently… CONTINUE READING